11 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
2452253	1	Synthesis and biological activity of CCK26-33-related analogues modified in position 31.	University Of Paris
3560164	14	Synthesis and binding affinities of analogues of cholecystokinin-(30-33) as probes for central nervous system cholecystokinin receptors.	TBA
2848124	401	Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists.	Merck Sharp & Dohme Research Laboratories
	10	Cholecystokinin analogues: The ergopeptine alkaloids as models of the active conformation of CCK	TBA
21493064	69	Discovery of pyrimidine carboxamides as potent and selective CCK1 receptor agonists.	Merck
	45	Synthesis and pharmacological evaluation of highly potent dual histamine H2 and gastrin receptor antagonists	TBA
	87	Design, synthesis, and pharmacological evaluation of dual histamine H2 and gastrin receptor antagonists	TBA
	40	Novel cholecystokinin receptor ligands: Oxopiperazines derived from Boc-CCK-4	TBA
18684621	59	2-Substituted piperazine-derived imidazole carboxamides as potent and selective CCK1R agonists for the treatment of obesity.	Merck
9925722	18	Pharmacological treatment of obesity: therapeutic strategies.	The R. W. Johnson Pharmaceutical Research Institute
2438407	14	Investigation of peripheral cholecystokinin receptor heterogeneity by cyclic and related linear analogues of CCK26-33: synthesis and biological properties.	TBA